Kyowa Hakko Kirin’s UK subsidiary is to expand its headquarters in Scotland to accommodate its growing business - at a time when other Japanese pharma companies have considered scaling back
After two FDA rejections for non-alcoholic steatohepatitis (NASH) therapy obeticholic acid (OCA), Intercept Pharma has agreed to be taken over by Italian drugmaker Alfasig
Drug discovery is usually a goal-driven and iterative process, as researchers look for innovative new routes to target particular diseases and study those diseases in afflicted patients to learn ho